Olaplex Holdings, Inc. (NASDAQ:OLPX – Get Free Report) insider Trisha Fox sold 26,426 shares of the company’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $1.26, for a total value of $33,296.76. Following the completion of the sale, the insider owned 721,169 shares of the company’s stock, valued at $908,672.94. This trade represents a 3.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Olaplex Price Performance
Shares of Olaplex stock opened at $1.20 on Friday. The stock has a market cap of $803.28 million, a P/E ratio of -120.00 and a beta of 2.24. The company has a debt-to-equity ratio of 0.40, a quick ratio of 4.00 and a current ratio of 4.58. The stock’s fifty day moving average is $1.54 and its 200 day moving average is $1.36. Olaplex Holdings, Inc. has a one year low of $0.99 and a one year high of $1.84.
Olaplex (NASDAQ:OLPX – Get Free Report) last released its quarterly earnings results on Thursday, March 5th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $105.12 million during the quarter, compared to analyst estimates of $104.21 million. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.Olaplex’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.01 earnings per share. Sell-side analysts anticipate that Olaplex Holdings, Inc. will post 0.1 earnings per share for the current year.
Institutional Trading of Olaplex
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on OLPX. Northland Securities assumed coverage on Olaplex in a research note on Thursday, November 20th. They set an “outperform” rating and a $2.00 price objective for the company. Morgan Stanley set a $1.40 target price on shares of Olaplex in a research note on Tuesday. Telsey Advisory Group reaffirmed a “market perform” rating and set a $2.00 price target on shares of Olaplex in a report on Monday, March 2nd. Evercore set a $2.50 price target on shares of Olaplex in a research report on Friday, March 6th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Olaplex in a research note on Wednesday, March 4th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $1.88.
Check Out Our Latest Stock Analysis on OLPX
Olaplex Company Profile
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
Featured Stories
- Five stocks we like better than Olaplex
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Iran isn’t the real war
- This coin has everything going for it
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
